1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Create Thread

Anonymous board for Ambu

Verification:

(CustomImgCaptcha By Surrey Forum)

Tags:

Multiple tags may be separated by commas.

Post a Poll

Possible Responses:
Maximum Selectable Responses:

This is the maximum number of responses a voter may select when voting.

Options: